JP2017507970A5 - - Google Patents

Download PDF

Info

Publication number
JP2017507970A5
JP2017507970A5 JP2016556899A JP2016556899A JP2017507970A5 JP 2017507970 A5 JP2017507970 A5 JP 2017507970A5 JP 2016556899 A JP2016556899 A JP 2016556899A JP 2016556899 A JP2016556899 A JP 2016556899A JP 2017507970 A5 JP2017507970 A5 JP 2017507970A5
Authority
JP
Japan
Prior art keywords
composition
hydroxyacetoxy
cyclopentyl
phenyl
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016556899A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017507970A (ja
JP6293919B2 (ja
Filing date
Publication date
Priority claimed from US14/285,488 external-priority patent/US20150259283A1/en
Application filed filed Critical
Publication of JP2017507970A publication Critical patent/JP2017507970A/ja
Publication of JP2017507970A5 publication Critical patent/JP2017507970A5/ja
Application granted granted Critical
Publication of JP6293919B2 publication Critical patent/JP6293919B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016556899A 2014-03-13 2015-03-12 ソフト型抗コリン作動薬類似体についての製剤 Active JP6293919B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201461952505P 2014-03-13 2014-03-13
US61/952,505 2014-03-13
US14/285,488 US20150259283A1 (en) 2014-03-13 2014-05-22 Formulation for soft anticholinergic analogs
US14/285,488 2014-05-22
PCT/US2015/020253 WO2015138776A1 (en) 2014-03-13 2015-03-12 Formulation for soft anticholinergic analogs

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017176799A Division JP6461267B2 (ja) 2014-03-13 2017-09-14 ソフト型抗コリン作動薬類似体についての製剤

Publications (3)

Publication Number Publication Date
JP2017507970A JP2017507970A (ja) 2017-03-23
JP2017507970A5 true JP2017507970A5 (enExample) 2017-10-26
JP6293919B2 JP6293919B2 (ja) 2018-03-14

Family

ID=54068191

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2016556899A Active JP6293919B2 (ja) 2014-03-13 2015-03-12 ソフト型抗コリン作動薬類似体についての製剤
JP2017176799A Active JP6461267B2 (ja) 2014-03-13 2017-09-14 ソフト型抗コリン作動薬類似体についての製剤
JP2018062716A Active JP6756763B2 (ja) 2014-03-13 2018-03-28 ソフト型抗コリン作動薬類似体についての製剤
JP2019127508A Active JP6762047B2 (ja) 2014-03-13 2019-07-09 ソフト型抗コリン作動薬類似体についての製剤
JP2020035073A Pending JP2020079321A (ja) 2014-03-13 2020-03-02 ソフト型抗コリン作動薬類似体についての製剤

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2017176799A Active JP6461267B2 (ja) 2014-03-13 2017-09-14 ソフト型抗コリン作動薬類似体についての製剤
JP2018062716A Active JP6756763B2 (ja) 2014-03-13 2018-03-28 ソフト型抗コリン作動薬類似体についての製剤
JP2019127508A Active JP6762047B2 (ja) 2014-03-13 2019-07-09 ソフト型抗コリン作動薬類似体についての製剤
JP2020035073A Pending JP2020079321A (ja) 2014-03-13 2020-03-02 ソフト型抗コリン作動薬類似体についての製剤

Country Status (20)

Country Link
US (8) US20150259283A1 (enExample)
EP (1) EP3116498B1 (enExample)
JP (5) JP6293919B2 (enExample)
KR (3) KR102433868B1 (enExample)
CN (3) CN110420167B (enExample)
AU (2) AU2015229243B2 (enExample)
BR (1) BR112016021011B1 (enExample)
CA (1) CA2941649C (enExample)
DK (2) DK3116498T3 (enExample)
ES (1) ES2710292T3 (enExample)
HU (1) HUE041868T2 (enExample)
IL (1) IL247571B (enExample)
MX (1) MX369129B (enExample)
MY (1) MY183531A (enExample)
PH (1) PH12016501732A1 (enExample)
PL (1) PL3116498T3 (enExample)
PT (2) PT3116498T (enExample)
SG (1) SG11201607480SA (enExample)
WO (1) WO2015138776A1 (enExample)
ZA (1) ZA201607071B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA200707352B (en) * 2005-03-03 2009-04-29 Revance Therapeutics Inc Compositions and methods for topical application and transdermal delivery of botulinum toxins
ES2658897T3 (es) 2011-08-24 2018-03-12 Novan, Inc. Macromoléculas de liberación de óxido nítrico ajustables que tienen múltiples estructuras donantes de óxido nítrico
US11813284B2 (en) 2013-08-08 2023-11-14 Novan, Inc. Topical compositions and methods of using the same
US20150259283A1 (en) 2014-03-13 2015-09-17 Brickell Biotech, Inc. Formulation for soft anticholinergic analogs
US10322082B2 (en) 2014-07-11 2019-06-18 Novan, Inc. Topical antiviral compositions and methods of using the same
CN119033771A (zh) 2015-07-21 2024-11-29 博多尔实验仪器公司 软性抗胆碱能药类似物的制剂
TWI767507B (zh) 2016-07-21 2022-06-11 美商波德實驗股份有限公司 軟性抗膽鹼類似物之製劑
US11381304B2 (en) * 2017-08-30 2022-07-05 Iridium Satellite Llc Satellite communications with multiple classes of terrestrial terminal devices
EP3972955A4 (en) * 2019-05-23 2023-07-05 Kaken Pharmaceutical Co., Ltd. CRYSTALLINE FORM OF SOFPIRONIUM BROMIDE AND ASSOCIATED METHOD OF PREPARATION
SG10201912063PA (en) * 2019-12-12 2021-07-29 Nat Skin Centre Singapore Pte Ltd A pharmaceutical formulation
WO2021177257A1 (ja) 2020-03-03 2021-09-10 科研製薬株式会社 原発性腋窩多汗症の治療方法、及びその医薬
CA3174550A1 (en) 2020-03-03 2021-09-10 Kaken Pharmaceutical Co., Ltd. Medicament containing sofpironium bromide
KR102655121B1 (ko) 2021-09-17 2024-04-08 한국식품연구원 락토바실러스 사케이 k040706 균주 검출용 프라이머 세트 및 이의 용도
US11807604B1 (en) * 2022-02-16 2023-11-07 Miralogx Llc Pharmaceutical compounds, pharmaceutical compositions, and methods of treating asthma and other disorders
WO2024026412A1 (en) * 2022-07-28 2024-02-01 Tff Pharmaceuticals, Inc. Thin film freezing methods and compositions formulated from dispersed active agents
KR102611847B1 (ko) * 2023-03-27 2023-12-12 주식회사 이플라스크 무스카린 수용체 길항 활성을 갖는 신규한 피롤리디늄 화합물 및 이의 용도

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK149832C (da) * 1981-07-17 1987-05-18 Riemann Claus Antiperspirantpraeparat bestaaende af to komponenter
DK483587D0 (da) * 1987-09-15 1987-09-15 Riemann & Co Aps Claus Antiperspirant praeparat
CA2014633C (en) * 1989-06-02 2000-07-18 Andrew D. Mccrea Stable anhydrous compositions for topical delivery of active materials
US5292530A (en) * 1991-06-02 1994-03-08 Helene Curtis, Inc. Stable anhydrous topically-active composition and suspending agent therefor
US5232689A (en) * 1990-12-21 1993-08-03 Dow Corning Corporation Translucent antiperspirant compositions
US5143719A (en) 1991-04-16 1992-09-01 Chesebrough-Pond's Usa Co. Anticalculus oral composition containing combinations of organophosphorus polycarboxylate cotelomers and inorganic polyphosphate salts
GB2280111B (en) 1993-07-16 1997-05-07 Union Camp Corp Clear gel antiperpirant compositions
US5895644A (en) * 1997-11-20 1999-04-20 Colgate-Palmolive Company Clear antiperspirant stick with dibenzylidene sorbitol and guar and process of making same
US6433003B1 (en) 1999-04-23 2002-08-13 Arthur M. Bobrove Method for treating hyperhidrosis in mammals
US6319491B1 (en) 2000-04-11 2001-11-20 Michael B. Whipple Anti-sweat lotion
EP1438001A4 (en) * 2001-09-26 2006-03-15 Alison B Lukacsko COMPOSITIONS AND METHODS FOR INHIBITING ECCRINS PERSPIRATION IN HUMANS
JP2003113392A (ja) 2001-10-04 2003-04-18 Kiyomitsu Kawasaki 芳香・消臭組成物および該芳香・消臭組成物を含有する人体用芳香・消臭剤
US8252316B2 (en) * 2002-05-03 2012-08-28 Purepharm Inc. Method of topically applying glycopyrrolate solution using absorbent pad to reduce sweating
BR0308051A (pt) 2003-12-15 2005-09-06 Natura Cosmeticos Sa Composição base para preparação de formulações multifuncionais para o cuidado e proteção da pele e cabelo
US7087560B2 (en) * 2004-10-25 2006-08-08 Unilever Home & Personal Care Usa, A Division Of Conopco, Inc. Personal care composition with salts of dihydroxypropyltri(C1-C3 alkyl) ammonium monosubstituted polyols
US20060088496A1 (en) * 2004-10-25 2006-04-27 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Personal care compositions with salts of hydroxypropyl trialkylammonium substituted mono-saccharide
GB0428416D0 (en) * 2004-12-24 2005-02-02 Novartis Ag Organic compounds
GB0428418D0 (en) * 2004-12-24 2005-02-02 Novartis Ag Organic compounds
WO2006069998A2 (de) * 2004-12-27 2006-07-06 Beiersdorf Ag Glycopyrrolat in kosmetischen zubereitungen
CN101340884A (zh) * 2005-10-19 2009-01-07 曼尼·马纳舍·辛格尔 用于治疗多汗症的方法
ATE529400T1 (de) 2005-11-10 2011-11-15 Nicholas S Bodor Weiche anticholinerge zwitterionen
ATE529399T1 (de) 2005-11-10 2011-11-15 Nicholas S Bodor Sanfte anticholinerge ester
AU2006201878A1 (en) * 2006-03-13 2007-09-27 Foamix Ltd Foamable composition for hyperhidrosis
JP5371235B2 (ja) * 2006-12-06 2013-12-18 ロート製薬株式会社 皮膚外用剤
US10265265B2 (en) * 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
ES2671874T3 (es) 2007-10-18 2018-06-11 Rose U, Llc Formulaciones tópicas de glicopirrolato
US20100137357A1 (en) * 2008-11-26 2010-06-03 Koleng John J Compositions and methods for hyperhidrosis
US20140037713A1 (en) * 2012-08-03 2014-02-06 Antares Pharma Ipl, Ag Transdermal compositions for anti-cholinergic agents
WO2014144075A1 (en) 2013-03-15 2014-09-18 Bodor Laboratories, Inc. Anticholinergic glycopyrrolate esters for the treatment of hyperhidrosis
US20150259283A1 (en) 2014-03-13 2015-09-17 Brickell Biotech, Inc. Formulation for soft anticholinergic analogs
JP2017507959A (ja) 2014-03-13 2017-03-23 ボドール ラボラトリーズ, インコーポレイテッド 選択された抗コリン作動性両性イオンの使用
CN119033771A (zh) 2015-07-21 2024-11-29 博多尔实验仪器公司 软性抗胆碱能药类似物的制剂
TWI767507B (zh) 2016-07-21 2022-06-11 美商波德實驗股份有限公司 軟性抗膽鹼類似物之製劑

Similar Documents

Publication Publication Date Title
JP2017507970A5 (enExample)
JP2017214429A5 (enExample)
JP2019189650A5 (enExample)
JP2016517431A5 (enExample)
JP2018520198A5 (enExample)
JP6461267B2 (ja) ソフト型抗コリン作動薬類似体についての製剤
FI3487475T3 (fi) Formulaatio pehmeille antikolinergisille analogeille
JP2016512246A5 (enExample)
JP2016532722A5 (enExample)
PH12020500543A1 (en) Nonracemic mixtures and uses thereof
JP2014525449A5 (enExample)
RU2017145649A (ru) КОМБИНИРОВАННАЯ ТЕРАПИЯ НА ОСНОВЕ АНТИТЕЛА К CD20 В СОЧЕТАНИИ С ИНГИБИТОРОМ BeI-2 И ИНГИБИТОРОМ MDM2
RU2015143409A (ru) Композиции для местного нанесения, содержащие биматопрост, и способы стимуляции роста волос с их помощью
JP2015007136A5 (enExample)
AU2020278236A8 (en) Methods of treating Sjögren's Syndrome using a Bruton's tyrosine kinase inhibitor
KR102732030B1 (ko) 아리피프라졸 주사가능한 제제의 투여 방법
SA521422467B1 (ar) مركبات هالو-آلِّيلامين واستخدامها
MX2017004476A (es) Composicion que comprende al menos un polvo seco obtenido por secado por atomizacion para aumentar la estabilidad de la formulacion.
JP2015522592A5 (enExample)
JP2016523226A5 (enExample)
EP3324968B1 (en) Therapeutic combinations of orally administered paclitaxel and a p-gp inhibitor for the treatment of cancer
EA202191130A1 (ru) Фармацевтическая композиция для лечения апластической анемии
RU2018130097A (ru) Лечение экземы кистей
RU2017134553A (ru) Хорошо растворимые в воде соли фенилалкиламина - быстродействующего блокатора кальциевых каналов, и их применение
JP2017516828A5 (enExample)